Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 47.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,019 shares of the company's stock after selling 7,167 shares during the quarter. Bridgewater Associates LP's holdings in Addus HomeCare were worth $1,067,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC purchased a new stake in Addus HomeCare in the 2nd quarter worth $31,000. Farther Finance Advisors LLC boosted its stake in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after buying an additional 366 shares during the last quarter. Innealta Capital LLC bought a new position in shares of Addus HomeCare during the 2nd quarter valued at approximately $44,000. Finally, Sandia Investment Management LP bought a new position in Addus HomeCare during the second quarter valued at $58,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Buying and Selling

In other news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company's stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the business's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,500 shares of company stock worth $1,668,265 in the last 90 days. 4.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on ADUS shares. TD Cowen raised their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an "overweight" rating and a $150.00 target price on the stock. Macquarie reiterated an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Royal Bank of Canada restated an "outperform" rating and set a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Oppenheimer lifted their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $131.63.

Addus HomeCare Trading Up 0.2 %

Shares of NASDAQ:ADUS traded up $0.25 on Monday, reaching $123.09. The company had a trading volume of 127,629 shares, compared to its average volume of 131,263. The firm has a market capitalization of $2.23 billion, a PE ratio of 28.02, a PEG ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12. The firm's 50 day simple moving average is $127.30 and its 200-day simple moving average is $123.75.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 earnings per share. As a group, equities research analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.